The rationale for development of ligelizumab in food allergy

Food allergy (FA) is a growing healthcare problem worldwide and the rising prevalence in many countries can be attributed to lifestyle, environmental, and nutritional changes. Immunoglobulin E (IgE)-mediated FA is the most common form of FA affecting approximately 3%–10% of adults and 8% of children...

Descripción completa

Detalles Bibliográficos
Autores principales: Wood, Robert A., Chinthrajah, R. Sharon, Eggel, Alexander, Bottoli, Ivan, Gautier, Aurelie, Woisetschlaeger, Maximilian, Tassinari, Paolo, Altman, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483652/
https://www.ncbi.nlm.nih.gov/pubmed/36185545
http://dx.doi.org/10.1016/j.waojou.2022.100690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483652/
https://www.ncbi.nlm.nih.gov/pubmed/36185545
http://dx.doi.org/10.1016/j.waojou.2022.100690

Ejemplares similares